Skip to main content
. 2012 May;56(5):2408–2413. doi: 10.1128/AAC.05194-11

Table 2.

Summary of the most commonly reported all-causality adverse events that occurred in more than two subjects in any treatment group

No. of subjects with adverse eventa No. of subjects (n = 48) with adverse event by treatment group:
Lersivirine (2,400 mg) Moxifloxacin (400 mg) Placebo
Headache 13 4 5
Nausea 11 0 0
Vomiting 5 0 0
Diarrhea 3 3 1
Abdominal discomfort 2 0 2
a

Shown are the Medical Dictionary for Regulatory Activities v12.1 preferred terms (19a).